Skip to Main Content

Paper Details

TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma.
Neuro Oncol
84
2018
C228T, C250T, E-twenty-six, ETS, ETS transcription factor, Meningiomas, Patients, TERT, TERT mRNA, TERT promoter, TERT promoter mutations, Telomerase, YK-4-279, benign tumors, meningioma, meningioma cells, meningiomas, patient, patients, promoter, telomerase, telomerase reverse transcriptase, telomerase reverse transcriptase (TERT) gene promoter, telomere, telomeric repeat, tumors
Author NameAffiliation
Johannes GojoMedical University Vienna
Josef PichlerKepler University Hospital
Serge WeisInstitute of Pathology and Neuropathology, Kepler University Hospital
  • 1 - 3

Datasets

Release 1.2